Susquehanna International Group’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $608K | Sell |
|
|||||
|
2025
Q2 | $2.51M | Sell |
|
|||||
|
2025
Q1 | $1.75M | Buy |
|
|||||
|
2024
Q4 | $1.22M | Buy |
|
|||||
|
2024
Q3 | $1.12M | Buy |
|
|||||
|
2024
Q2 | $531K | Sell |
|
|||||
|
2024
Q1 | $1.03M | Sell |
|
|||||
|
2023
Q4 | $771K | Sell |
|
|||||
|
2023
Q3 | $1.25M | Sell |
|
|||||
|
2023
Q2 | $2.19M | Buy |
|
|||||
|
2023
Q1 | $2.15M | Buy |
|
|||||
|
2022
Q4 | $420K | Sell |
|
|||||
|
2022
Q3 | $1.42M | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $1.41M | Sell |
|
|||||
|
2021
Q4 | $2.49M | Buy |
|
|||||
|
2021
Q3 | $1.43M | Buy |
|
|||||
|
2021
Q2 | $856K | Sell |
|
|||||
|
2021
Q1 | $1.49M | Buy |
|